FDA Commissioner Robert Califf responded to questions from members of the House Energy and Commerce Committee this week about the agency’s response to the COVID-19 pandemic, including their concerns about the agency’s ability to oversee the pharmaceutical supply chain.
Source: Drug Industry Daily